# A Safety and Tolerability Study of Administration of PSD502

> **NCT01183208** · PHASE1 · COMPLETED · sponsor: **Plethora Solutions Ltd** · enrollment: 21 (actual)

## Conditions studied

- Premature Ejaculation

## Interventions

- **DRUG:** Intervention A
- **DRUG:** Intervention B
- **DRUG:** Intervention C
- **DRUG:** Intervention D
- **DRUG:** Intervention E

## Key facts

- **NCT ID:** NCT01183208
- **Lead sponsor:** Plethora Solutions Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2016-08-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01183208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01183208, "A Safety and Tolerability Study of Administration of PSD502". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01183208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*